The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pan-sarcoma analysis of DNA damage response pathway alterations and deficiency.
 
Steven Bialick
No Relationships to Disclose
 
Kurt Statz-Geary
Stock and Other Ownership Interests - AstraZeneca Canada; Biomarin; Boston Scientific; Iovance Biotherapeutics; UnitedHealthcare; Vertex
 
Andrew Elliott
Employment - Caris Life Sciences
 
Jim Abraham
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Stock and Other Ownership Interests - Caris Life Sciences
 
Phillip Walker
Employment - Caris Life Sciences
 
Andrea P. Espejo-Freire
No Relationships to Disclose
 
Priscila Barreto Coelho
No Relationships to Disclose
 
Philippos Apolinario Costa
No Relationships to Disclose
 
Kirsten Leu
No Relationships to Disclose
 
Margaret von Mehren
Consulting or Advisory Role - deciphera; GlaxoSmithKline
Research Funding - ASCO (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Novartis (Inst); Solaris Health (Inst)
Patents, Royalties, Other Intellectual Property - cell line
Other Relationship - NCCN
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Daiichi Sankyo/Lilly; Deciphera; Epizyme
 
Emily Jonczak
No Relationships to Disclose
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis
 
Andrew Rosenberg
No Relationships to Disclose
 
Aditi Dhir
No Relationships to Disclose